Emmaus Life Sciences Inc (EMMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EMMA | AMGN | VRTX | GILD | BMY |
| Company | Emmaus Life Sciences Inc | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.0134 | 316.08 | 415.61 | 123.89 | 46.72 |
| High | 0.0134 | 321.42 | 416.27 | 124.00 | 46.99 |
| Low | 0.0134 | 314.00 | 406.67 | 117.54 | 46.32 |
| Last | 0.0134 | 320.20 | 409.47 | 118.84 | 46.69 |
| Change | +0.0015 | +4.61 | -6.78 | -4.56 | +0.06 |
| % Change | +12.61% | +1.46% | -1.63% | -3.70% | +0.13% |
| Volume | 13,000 | 2,665,300 | 1,357,900 | 9,065,900 | 9,007,500 |
| 20-Day Average Volume | 112,305 | 2,346,990 | 1,357,435 | 7,000,785 | 16,342,450 |
| Previous Close | 0.0119 | 315.59 | 416.25 | 123.40 | 46.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0117 | 298.87 | 418.22 | 120.55 | 44.50 |
| 20-Day Raw Stochastic | 58.70% | 92.05% | 22.83% | 45.51% | 93.08% |
| 20-Day Relative Strength | 54.40 | 66.82 | 47.94 | 51.07 | 57.84 |
| Weighted Alpha | -58.89 | +6.33 | -18.14 | +23.69 | -14.05 |
| Today's Opinion | 32% Sell | 56% Buy | 56% Sell | 88% Buy | 40% Sell |
| Previous Opinion | 40% Sell | 56% Buy | 56% Sell | 100% Buy | 40% Sell |
| Last Month's Opinion | 72% Sell | 8% Sell | 56% Sell | 88% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +28.85% since 10/29/25 | +7.29% since 10/31/25 | -3.78% since 10/31/25 | -0.79% since 10/31/25 | +1.35% since 10/31/25 |
| Low | 0.0093 on 11/04/25 | 292.12 on 11/03/25 | 403.16 on 11/04/25 | 117.54 on 11/07/25 | 45.38 on 11/04/25 |
| High | 0.0134 on 11/07/25 | 322.98 on 11/05/25 | 430.71 on 11/04/25 | 124.10 on 11/06/25 | 47.00 on 11/06/25 |
| 1-Month | |||||
| %Chg | -9.46% since 10/07/25 | +8.34% since 10/07/25 | -0.20% since 10/07/25 | +1.76% since 10/07/25 | +4.55% since 10/07/25 |
| Low | 0.0080 on 10/20/25 | 288.00 on 10/31/25 | 402.58 on 10/13/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 0.0172 on 10/09/25 | 322.98 on 11/05/25 | 432.76 on 10/23/25 | 124.61 on 10/21/25 | 47.00 on 11/06/25 |
| 3-Month | |||||
| %Chg | -4.29% since 08/07/25 | +12.47% since 08/07/25 | +9.01% since 08/07/25 | +7.76% since 08/07/25 | +2.93% since 08/07/25 |
| Low | 0.0080 on 10/20/25 | 269.77 on 09/26/25 | 362.50 on 08/11/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 0.0172 on 10/09/25 | 322.98 on 11/05/25 | 432.76 on 10/23/25 | 124.61 on 10/21/25 | 49.58 on 08/20/25 |
| 6-Month | |||||
| %Chg | +3.08% since 05/06/25 | +16.08% since 05/07/25 | -5.83% since 05/07/25 | +20.16% since 05/07/25 | -1.95% since 05/07/25 |
| Low | 0.0080 on 10/20/25 | 261.43 on 05/14/25 | 362.50 on 08/11/25 | 95.29 on 05/08/25 | 42.52 on 10/29/25 |
| High | 0.0199 on 05/30/25 | 322.98 on 11/05/25 | 484.56 on 07/10/25 | 124.61 on 10/21/25 | 50.76 on 06/11/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 856 | 172,421,616 | 103,890,320 | 147,457,504 | 95,049,312 |
| Shares Outstanding, K | 63,866 | 538,481 | 253,719 | 1,240,807 | 2,035,753 |
| Annual Sales | 16,650,000 | 33,424,000,000 | 11,020,100,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | -6,450,000 | 4,090,000,000 | -535,600,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 2,820,000 | 9,179,000,000 | 2,964,700,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | -1,140,000 | 1,432,000,000 | 1,032,900,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | 7.41 | 0.45 | 0.36 | 0.32 | 0.33 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 08/14/25 | 5.64 on 11/04/25 | 4.80 on 11/03/25 | 2.47 on 10/30/25 | 1.63 on 10/30/25 |
| Latest Earnings Date | 11/18/25 | 11/04/25 | 11/03/25 | 10/30/25 | 10/30/25 |
| Most Recent Dividend | N/A | 2.380 on 08/22/25 | N/A | 0.790 on 09/15/25 | 0.620 on 10/03/25 |
| Next Ex-Dividends Date | N/A | 11/21/25 | N/A | 12/15/25 | 10/03/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.43 | 27.19 | 15.07 | 7.11 |